Mia Arnhult
Born 1969
Director since 2010 and Chair of the Board since 2021
Education:
Degree in business economics and trade law, Lund University.
Other important offices:
Director of Meds Apotek AB, director of M2 Asset Management AB and Chair of the Board of Lidingöloppet.
Previous positions:
Auditor at Lindebergs Grant Thornton AB, CFO at M2 Gruppen and Corem Property Group AB and CEO of M2 Asset Management AB. Director of Odd Molly International, Bactiguard Holding, Footway Group and Nanexa.
Shares:
1,200 Company shares and 4,035,000 through related parties.
Independent of the Company and company management, not independent of the Company’s major shareholders.
Fredrik Dahl
Born 1977
Board member since 2021
Education:
PhD in molecular medicine, Uppsala University, postdoctoral studies at Stanford Genome Technology Center, Stanford University.
Other important offices:
Director of Pixelgen Technologies AB, Mindforce Game Lab AB, Nucleus Capital AB and Colibri Ventures AB.
Previous positions:
Founder and CTO of Vanadis Diagnostics AB and Halo Genomics AB.
Shares:
34,150 Company shares.
Independent of the Company and company management, and independent of the Company's major shareholders.
Pia Gideon
Born 1954
Board member since 2021
Education:
M.Sc. in Business and Economics, Stockholm School of Economics.
Other important offices:
Chair of Qlucore AB and Director of Skandi Standard AB, Apoteket AB and Gideon Partners AB.
Previous positions:
Chair of the Board of Directors of Action Aid AB, Klövern AB and Simris Alg AB, Board member of Metria AB, Min Doktor AB, Guards Therapeutics AB and Proact AB.
Shares:
2,450 Company shares.
Independent of the Company and company management, and independent of the Company's major shareholders.
Thomas Eklund
Born in 1967
Board member since 2024
Education:
M.Sc. in Business and Economics and MBA, Stockholm School of Economics.
Other important offices:
Director of Boule Diagnostics AB, Immedica Pharma Holding AB, Surgical Science Sweden AB and Swedencare AB (publ) as well as board member in smaller subsidiaries of these companies or smaller family companies.
Previous positions:
CEO of Investor Growth Capital (now Patricia Industries) during the years 2002–2012, board member in life science companies such as Swedish Orphan International AB (chairman), Carmel Pharma AB, Mabtech Group Holding AB and Mabtech Holding AB.
Shares:
107,605 Company shares and 1,000 through related parties.
Independent of the Company and company management, and independent of the Company's major shareholders.
Isabelle Ducellier
Born 1969
Member of the Board since 2025.
Education:
Master of Business Administration from EmLyon Business School. Executive MBA from both INSEAD and Harvard Business School.
Other important offices:
Board member of Lyko. Board assignments in Björn Borg, NutraQ, Orkla Wound Care, Jönköping Business School, TwoPac Laboratories AB and TwoPac Machine AB.
Previous positions:
Long experience of building consumer brands in international environments. CEO of Orkla Health, BioGaia and Pernod Ricard Sweden, as well as Secretary General of the Swedish Childhood Cancer Foundation.
Shares:
465 Company shares
Olof Ericsson
Born 1978
Member of the Board since 2025.
Education:
PhD in molecular medicine from Uppsala University.
Other important offices:
Board member and CEO of Moleculent AB and board member of OneLab AB and Faboss Invest AB.
Previous positions:
Extensive experience from roles as CEO and marketing manager in the life science and diagnostics sector. CEO of Halo Genomics and Vanadis Diagnostics. Global Head of Marketing for Agilent Genomics and PerkinElmer.
Shares: -